摘要
低氧诱导因子(HIF)是恶性肿瘤适应低氧微环境的关键因子,已成为恶性肿瘤抑制剂及基因治疗研究的重要靶点,本文综述其在肿瘤抑制剂治疗中的研究进展。
Hypoxia-inducible factor(HIF) plays a key role in the adaptation of tumour cells under hypoxic circumstance, there are some advances in the literatures regarding HIF as an important target for anticancer agents and gene therapy, In this review, the molecular mechanism and clinical significance of compounds targeting on hypoxiainducing factor was summarized.
出处
《中国癌症杂志》
CAS
CSCD
2008年第11期866-869,共4页
China Oncology
基金
国家自然科学基金资助项目(No.30660192)
江西省研究生创新基金(No.YC07A018)
关键词
低氧
肿瘤
治疗
抑制剂
hypoxia
neoplasms
therapy
inhibitor